Transdermal dopaminergic D<sub>2</sub> receptor agonist therapy in Parkinson's disease with N‐0923 TDS: A double‐blind, placebo‐controlled studyJ. Thomas Hutton, Jerry L. Morris, Thomas N. Chase et al.|Movement Disorders|2001Cited by 60